Skip to main content
Erschienen in: Digestive Diseases and Sciences 10/2021

15.10.2020 | Original Article

Microscopic Colitis Is Not an Independent Risk Factor for Low Bone Density

verfasst von: Elliot J. Graziano, Byron P. Vaughn, Qi Wang, Lisa S. Chow, James P. Campbell

Erschienen in: Digestive Diseases and Sciences | Ausgabe 10/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Microscopic colitis (MC) is a subtype of inflammatory bowel disease (IBD) with overlapping risk factors for low bone density (LBD). While LBD is a known complication of IBD, its association with MC is not well-established.

Aims

Assess the prevalence of LBD in MC compared to control populations, and evaluate if MC predicts LBD when controlling for confounders.

Methods

Retrospective, observational case control study of adult patients with pathologically confirmed MC from 2005 to 2015. Bone density measurements were abstracted from dual-energy X-ray absorptiometry (DEXA) reports, and bone density was classified using T-score: normal (T ≥ − 1.0), osteopenia (− 1.0 > T > -2.5) or osteoporosis (T ≤ − 2.5). Demographics, disease, medication history and LBD risk factors were obtained from chart review. Prevalence of LBD was compared to national and local controls. A matched control cohort to MC patients without prior diagnosis of LBD was analyzed with logistic regression to assess the relationship of MC to LBD.

Results

One hundred and eighteen patients with MC were identified. Osteopenia in women with MC was more prevalent compared to national controls (67% vs. 49%, p = 0.0004), and LBD was more prevalent in MC patients compared to local controls (82% vs. 55%, p < 0.0001). In MC patients without prior diagnosis of LBD matched to controls, there was a higher prevalence of osteopenia (53.2% vs. 36.7%, p = 0.04). However, after controlling for confounders, MC was not associated with LBD (OR 0.83, 95% CI 0.22, 3.16, p = 0.8).

Conclusions

While LBD was more prevalent in MC patients compared to control populations, with adjustment for key confounders (including BMI, steroids, smoking, vitamin D and calcium use), MC was not an independent predictor of LBD.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Park T, Cave D, Marshall C. Microscopic colitis: a review of etiology, treatment and refractory disease. World J Gastroenterol. 2015;21:8804–8810.CrossRef Park T, Cave D, Marshall C. Microscopic colitis: a review of etiology, treatment and refractory disease. World J Gastroenterol. 2015;21:8804–8810.CrossRef
2.
Zurück zum Zitat Vestergaard P. Bone loss associated with gastrointestinal disease: prevalence and pathogenesis. Eur J Gastroenterol Hepatol. 2003;15:851–856.CrossRef Vestergaard P. Bone loss associated with gastrointestinal disease: prevalence and pathogenesis. Eur J Gastroenterol Hepatol. 2003;15:851–856.CrossRef
3.
Zurück zum Zitat Compston JE, Judd D, Crawley EO, et al. Osteoporosis in patients with inflammatory bowel disease. Gut. 1987;28:410–415.CrossRef Compston JE, Judd D, Crawley EO, et al. Osteoporosis in patients with inflammatory bowel disease. Gut. 1987;28:410–415.CrossRef
4.
Zurück zum Zitat Bernstein CN, Blanchard JF, Metge C, Yogendran M. The association between corticosteroid use and development of fractures among IBD patients in a population-based database. Am J Gastroenterol. 2003;98:1797–1801.CrossRef Bernstein CN, Blanchard JF, Metge C, Yogendran M. The association between corticosteroid use and development of fractures among IBD patients in a population-based database. Am J Gastroenterol. 2003;98:1797–1801.CrossRef
5.
Zurück zum Zitat Lorinczy K, Lakatos G, Müllner K, et al. Low bone mass in microscopic colitis. BMC Gastroenterol. 2011;11:58.CrossRef Lorinczy K, Lakatos G, Müllner K, et al. Low bone mass in microscopic colitis. BMC Gastroenterol. 2011;11:58.CrossRef
6.
Zurück zum Zitat Wildt S, Munck LK, Becker S, Brockstedt H, Bonderup OK, Hitz MF. Risk of osteoporosis in microscopic colitis. Postgrad Med. 2018;130:348–354.CrossRef Wildt S, Munck LK, Becker S, Brockstedt H, Bonderup OK, Hitz MF. Risk of osteoporosis in microscopic colitis. Postgrad Med. 2018;130:348–354.CrossRef
7.
Zurück zum Zitat Cino M, Greenberg GR. Bone mineral density in Crohn’s disease: a longitudinal study of budesonide, prednisone, and nonsteroid therapy. Am J Gastroenterol. 2002;97:915–921.CrossRef Cino M, Greenberg GR. Bone mineral density in Crohn’s disease: a longitudinal study of budesonide, prednisone, and nonsteroid therapy. Am J Gastroenterol. 2002;97:915–921.CrossRef
8.
Zurück zum Zitat Tong J, Zheng Q, Zhang C, Lo R, Shen J, Ran Z. Incidence, prevalence, and temporal trends of microscopic colitis: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110:265–276. quiz 77.CrossRef Tong J, Zheng Q, Zhang C, Lo R, Shen J, Ran Z. Incidence, prevalence, and temporal trends of microscopic colitis: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110:265–276. quiz 77.CrossRef
9.
Zurück zum Zitat Gentile N, Yen EF. Prevalence, pathogenesis, diagnosis, and management of microscopic colitis. Gut Liver. 2018;12:227–235.CrossRef Gentile N, Yen EF. Prevalence, pathogenesis, diagnosis, and management of microscopic colitis. Gut Liver. 2018;12:227–235.CrossRef
10.
Zurück zum Zitat Bolton JM, Targownik LE, Leung S, Sareen J, Leslie WD. Risk of low bone mineral density associated with psychotropic medications and mental disorders in postmenopausal women. J Clin Psychopharmacol. 2011;31:56–60.CrossRef Bolton JM, Targownik LE, Leung S, Sareen J, Leslie WD. Risk of low bone mineral density associated with psychotropic medications and mental disorders in postmenopausal women. J Clin Psychopharmacol. 2011;31:56–60.CrossRef
11.
Zurück zum Zitat Andersen BN, Johansen PB, Abrahamsen B. Proton pump inhibitors and osteoporosis. Curr Opin Rheumatol. 2016;28:420–425.CrossRef Andersen BN, Johansen PB, Abrahamsen B. Proton pump inhibitors and osteoporosis. Curr Opin Rheumatol. 2016;28:420–425.CrossRef
12.
Zurück zum Zitat Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG clinical guideline: preventive care in inflammatory bowel disease. Am J Gastroenterol. 2017;112:241–258.CrossRef Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG clinical guideline: preventive care in inflammatory bowel disease. Am J Gastroenterol. 2017;112:241–258.CrossRef
13.
Zurück zum Zitat Curry SJ, Krist AH, Owens DK, et al. Screening for osteoporosis to prevent fractures: US preventive services task force recommendation statement. JAMA. 2018;319:2521–2531.CrossRef Curry SJ, Krist AH, Owens DK, et al. Screening for osteoporosis to prevent fractures: US preventive services task force recommendation statement. JAMA. 2018;319:2521–2531.CrossRef
14.
Zurück zum Zitat Looker AC, Melton LJ 3rd, Harris TB, Borrud LG, Shepherd JA. Prevalence and trends in low femur bone density among older US adults: NHANES 2005-2006 compared with NHANES III. J Bone Miner Res. 2010;25:64–71.CrossRef Looker AC, Melton LJ 3rd, Harris TB, Borrud LG, Shepherd JA. Prevalence and trends in low femur bone density among older US adults: NHANES 2005-2006 compared with NHANES III. J Bone Miner Res. 2010;25:64–71.CrossRef
15.
Zurück zum Zitat Pardi DS. Diagnosis and management of microscopic colitis. Am J Gastroenterol. 2017;112:78–85.CrossRef Pardi DS. Diagnosis and management of microscopic colitis. Am J Gastroenterol. 2017;112:78–85.CrossRef
16.
Zurück zum Zitat Rasmussen MA, Munck LK. Systematic review: are lymphocytic colitis and collagenous colitis two subtypes of the same disease—microscopic colitis? Aliment Pharmacol Ther. 2012;36:79–90.CrossRef Rasmussen MA, Munck LK. Systematic review: are lymphocytic colitis and collagenous colitis two subtypes of the same disease—microscopic colitis? Aliment Pharmacol Ther. 2012;36:79–90.CrossRef
17.
Zurück zum Zitat Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol. 2006;194:S3–S11.CrossRef Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol. 2006;194:S3–S11.CrossRef
18.
Zurück zum Zitat Klibanski A, Adams-Campbell L, Bassford TL, et al. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785–795.CrossRef Klibanski A, Adams-Campbell L, Bassford TL, et al. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785–795.CrossRef
19.
Zurück zum Zitat Jaruvongvanich V, Poonsombudlert K, Ungprasert P. Smoking and risk of microscopic colitis: a systematic review and meta-analysis. Inflamm Bowel Dis. 2019;25:672–678.CrossRef Jaruvongvanich V, Poonsombudlert K, Ungprasert P. Smoking and risk of microscopic colitis: a systematic review and meta-analysis. Inflamm Bowel Dis. 2019;25:672–678.CrossRef
20.
Zurück zum Zitat Williams JJ, Kaplan GG, Makhija S, et al. Microscopic colitis-defining incidence rates and risk factors: a population-based study. Clin Gastroenterol Hepatol. 2008;6:35–40.CrossRef Williams JJ, Kaplan GG, Makhija S, et al. Microscopic colitis-defining incidence rates and risk factors: a population-based study. Clin Gastroenterol Hepatol. 2008;6:35–40.CrossRef
21.
Zurück zum Zitat Gentile NM, Khanna S, Loftus EV, et al. The epidemiology of microscopic colitis in olmsted county from 2002–2010: a population-based study. Clin Gastroenterol Hepatol. 2014;12:838–842.CrossRef Gentile NM, Khanna S, Loftus EV, et al. The epidemiology of microscopic colitis in olmsted county from 2002–2010: a population-based study. Clin Gastroenterol Hepatol. 2014;12:838–842.CrossRef
22.
Zurück zum Zitat Asomaning K, Bertone-Johnson ER, Nasca PC, Hooven F, Pekow PS. The association between body mass index and osteoporosis in patients referred for a bone mineral density examination. J Womens Health (Larchmt). 2006;15:1028–1034.CrossRef Asomaning K, Bertone-Johnson ER, Nasca PC, Hooven F, Pekow PS. The association between body mass index and osteoporosis in patients referred for a bone mineral density examination. J Womens Health (Larchmt). 2006;15:1028–1034.CrossRef
23.
Zurück zum Zitat Weinstein RS. Glucocorticoid-induced osteoporosis and osteonecrosis. Endocrinol Metab Clin N Am. 2012;41:595–611.CrossRef Weinstein RS. Glucocorticoid-induced osteoporosis and osteonecrosis. Endocrinol Metab Clin N Am. 2012;41:595–611.CrossRef
Metadaten
Titel
Microscopic Colitis Is Not an Independent Risk Factor for Low Bone Density
verfasst von
Elliot J. Graziano
Byron P. Vaughn
Qi Wang
Lisa S. Chow
James P. Campbell
Publikationsdatum
15.10.2020
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 10/2021
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06651-2

Weitere Artikel der Ausgabe 10/2021

Digestive Diseases and Sciences 10/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.